Skip to main content
Top
Published in: Journal of General Internal Medicine 7/2020

01-07-2020 | Addiction | Concise Research Report

Increased Awareness Needed for Inpatient Substance Use Disorder Treatment in Drug Use–Associated Infective Endocarditis

Authors: Alexandra E. Mihm, PharmD, Mary C. Cash, PharmD Candidate, Sarah A. Nisly, PharmD, Kyle A. Davis, PharmD

Published in: Journal of General Internal Medicine | Issue 7/2020

Login to get access

Excerpt

The incidence of drug use–associated infective endocarditis (DUA-IE) has increased in the USA, with North Carolina witnessing an extreme 12-fold increase in cases over the past decade.1 While patients are at increased risk of morbidity and mortality, inpatient IE management primarily focuses on treating the acute infection, leaving the underlying substance use disorder unaddressed.1, 2 Utilization of substance abuse resources, including medication-assisted treatment (MAT), during inpatient treatment may prevent further abuse; minimize recurrent infections, readmissions, and mortality; and reduce healthcare costs.2, 3 Much remains unknown surrounding patient characteristics and resources offered during hospitalization for DUA-IE and the impact of resources on patient outcomes. The objective of this study was to describe and evaluate substance abuse resources offered during inpatient DUA-IE treatment. …
Literature
1.
go back to reference Schranz AJ, Fleischauer A, Chu VH, Wu LT, Rosen DL. Trends in drug use-associated infective endocarditis and heart valve surgery, 2007 to 2017. Ann Intern Med. 2019;170(1):31–40.CrossRef Schranz AJ, Fleischauer A, Chu VH, Wu LT, Rosen DL. Trends in drug use-associated infective endocarditis and heart valve surgery, 2007 to 2017. Ann Intern Med. 2019;170(1):31–40.CrossRef
2.
go back to reference Rosenthal ES, Karchmer AW, Theisen-Toupal J, Castillo RA, Rowley CF. Suboptimal addiction interventions for patients hospitalized with injection drug use-associated infective endocarditis. Am J Med. 2016;129(5):481–485.CrossRef Rosenthal ES, Karchmer AW, Theisen-Toupal J, Castillo RA, Rowley CF. Suboptimal addiction interventions for patients hospitalized with injection drug use-associated infective endocarditis. Am J Med. 2016;129(5):481–485.CrossRef
3.
go back to reference Bates MC, Annie F, Jha A, Kerns F. Increasing incidence of IV-drug use associated endocarditis in southern West Virginia and potential economic impact. Clin Cardiol. 2019;42(4):432–437.CrossRef Bates MC, Annie F, Jha A, Kerns F. Increasing incidence of IV-drug use associated endocarditis in southern West Virginia and potential economic impact. Clin Cardiol. 2019;42(4):432–437.CrossRef
4.
go back to reference Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30(4):633–638.CrossRef Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30(4):633–638.CrossRef
5.
go back to reference Gray ME, Rogawski McQuade ET, Scheld WM, Dillingham RA. Rising rates of injection drug use associated infective endocarditis in Virginia with missed opportunities for addiction treatment referral: a retrospective cohort study. BMC Infect Dis. 2018;18(1):532.CrossRef Gray ME, Rogawski McQuade ET, Scheld WM, Dillingham RA. Rising rates of injection drug use associated infective endocarditis in Virginia with missed opportunities for addiction treatment referral: a retrospective cohort study. BMC Infect Dis. 2018;18(1):532.CrossRef
Metadata
Title
Increased Awareness Needed for Inpatient Substance Use Disorder Treatment in Drug Use–Associated Infective Endocarditis
Authors
Alexandra E. Mihm, PharmD
Mary C. Cash, PharmD Candidate
Sarah A. Nisly, PharmD
Kyle A. Davis, PharmD
Publication date
01-07-2020
Publisher
Springer International Publishing
Published in
Journal of General Internal Medicine / Issue 7/2020
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-019-05607-1

Other articles of this Issue 7/2020

Journal of General Internal Medicine 7/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.